Your browser doesn't support javascript.
loading
ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.
Zhao, Tiansuo; Jiang, Wenna; Wang, Xiuchao; Wang, Hongwei; Zheng, Chen; Li, Yang; Sun, Yan; Huang, Chongbiao; Han, Zhi-Bo; Yang, Shengyu; Jia, Zhiliang; Xie, Keping; Ren, He; Hao, Jihui.
Afiliação
  • Zhao T; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Jiang W; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang X; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Wang H; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Zheng C; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Li Y; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Sun Y; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Huang C; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China.
  • Han ZB; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
  • Yang S; Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R. China.
  • Jia Z; Department of Tumor Biology and Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Xie K; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ren H; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas. kepxie@mdanderson.org haojihui@tjmuch.com renhe@tjmuch.com.
  • Hao J; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin, P.R. China.
Cancer Res ; 77(4): 874-885, 2017 02 15.
Article em En | MEDLINE | ID: mdl-27923832
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Fatores de Transcrição / Caderinas / Carcinoma Ductal Pancreático / Proteínas Supressoras de Tumor / Metástase Neoplásica Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Fatores de Transcrição / Caderinas / Carcinoma Ductal Pancreático / Proteínas Supressoras de Tumor / Metástase Neoplásica Idioma: En Ano de publicação: 2017 Tipo de documento: Article